Inflexion-backed CNX Therapeutics snaps up Sativex

Sativex is indicated for symptom improvement in adult patients with moderate to severe spasticity.

3 November 2025•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.